Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). We evaluated chemotherapy tolerance and oncologic outcomes from the medical records of patients with CRC with and without IBD. In this series, patients with CRC with IBD experienced more treatment alterations than those w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Colorectal Cancer
Autori principali: Axelrad, Jordan, Kriplani, Anuja, Ozbek, Umut, Harpaz, Noam, Colombel, Jean-Frederic, Itzkowitz, Steven, Holcombe, Randall F., Ang, Celina
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6009836/
https://ncbi.nlm.nih.gov/pubmed/27742264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2016.09.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi